Skip to main content

Peer Review reports

From: Precision medicine approaches to lung adenocarcinoma with concomitant MET and HER2 amplification

Original Submission
7 Jan 2016 Submitted Original manuscript
10 Feb 2016 Reviewed Reviewer Report - Yoon Soo Chang
17 Mar 2016 Reviewed Reviewer Report - Laura Bonanno
2 Feb 2017 Reviewed Reviewer Report - Medhi Wangpaichitr
24 Mar 2017 Author responded Author comments - Doo-Yi Oh
Resubmission - Version 2
24 Mar 2017 Submitted Manuscript version 2
15 Apr 2017 Reviewed Reviewer Report - Yoon Soo Chang
4 Jun 2017 Author responded Author comments - Doo-Yi Oh
Resubmission - Version 3
4 Jun 2017 Submitted Manuscript version 3
7 Jul 2017 Author responded Author comments - Doo-Yi Oh
Resubmission - Version 4
7 Jul 2017 Submitted Manuscript version 4
20 Jul 2017 Author responded Author comments - Doo-Yi Oh
Resubmission - Version 5
20 Jul 2017 Submitted Manuscript version 5
Publishing
1 Aug 2017 Editorially accepted
10 Aug 2017 Article published 10.1186/s12885-017-3525-9

You can find further information about peer review here.

Back to article page